BRECCIA, MARTINA
BRECCIA, MARTINA
Dipartimento di Biotecnologie Mediche e Medicina Traslazionale
INVESTIGATING THE ROLE OF DEFECTIVE CELL TO CELL COMMUNICATION MECHANISMS IN RETT SYNDROME PATHOGENESIS
2025 M. Breccia
Role of IL-6 in Rett syndrome: from in vitro findings to in vivo therapeutic target validation
2025 O. Roggero, M. Breccia, F. Biella, F. Postogna, E. Boda, A. Frasca
Cholesterol dysregulation in Rett syndrome: implications for synaptic function
2025 F. Postogna, M. Breccia, O. Roggero, F. Biella, C. Cabasino, A. Arcari, N. Giancroce, N. Landsberger, A. Frasca
Role of IL-6 in Rett syndrome: from in vitro findings to in vivo therapeutic target validation
2025 O. Roggero, M. Breccia, F. Postogna, F. Biella, N. Landsberger, E. Boda, A. Frasca
Identification of novel molecules by which Mecp2 knock-out astrocytes exert a synaptotoxic action on neurons
2024 A. Frasca, F. Postogna, M. Breccia, E. Albizzati, D. Pozzi, E. Boda, N. Landsberger
Reduction in cholesterol supply by Mecp2 null astrocytes contributes to synaptic defects
2024 F. Postogna, M. Breccia, O. Roggero, F. Biella, E. Albizzati, C. Cabasino, A. Arcari, D. Colombo, L. Morelli, E. Chiricozzi, N. Landsberger, A. Frasca
Role of interleukin 6 in the pathogenesis of Rett syndrome: focus on astrocyte-neuron crosstalk and its therapeutic implication
2024 O. Roggero, M. Breccia, F. Biella, F. Postogna, N. Landsberger, A. Frasca
Unraveling autophagic imbalances and therapeutic insights in Mecp2-deficient models
2024 A. Esposito, T. Seri, M. Breccia, M. Indrigo, G. De Rocco, F. Nuzzolillo, V. Denti, F. Pappacena, G. Tartaglione, S. Serrao, G. Paglia, L. Murru, S. de Pretis, J. Cioni, N. Landsberger, F.C. Guarnieri, M. Palmieri
Mecp2 knock-out astrocytes affect synaptogenesis by Interleukin 6 dependent mechanisms
2024 E. Albizzati, M. Breccia, E.M. Florio, C. Cabasino, F.M. Postogna, R. Grassi, E. Boda, C. Battaglia, C. DE PALMA, C. De Quattro, D. Pozzi, N. Landsberger, A. Frasca
Clinical-grade intranasal NGF fuels neurological and metabolic functions of Mecp2-deficient mice
2024 D. Pozzer, M. Indrigo, M. Breccia, E. Florio, C.A. Franchino, G. De Rocco, F. Maltecca, A. Fadda, M. Rossato, A. Aramini, M. Allegretti, A. Frasca, L. De Filippis, N. Landsberger
GM1 Oligosaccharide Ameliorates Rett Syndrome Phenotypes In Vitro and In Vivo via Trk Receptor Activation
2024 M. Fazzari, G. Lunghi, E.V. Carsana, M. Valsecchi, E. Spiombi, M. Breccia, S.R. Casati, S. Pedretti, N. Mitro, L. Mauri, M.G. Ciampa, S. Sonnino, N. Landsberger, A. Frasca, E. Chiricozzi
MeCP2 deficiency in astrocytes alters synaptogenesis: new insights on Rett syndrome
2023 M. Breccia, E. Albizzati, E. Florio, C. Cabasino, D. Pozzi, E. Boda, C. Battaglia, C. De Palma, C. De Quattro, N. Landsberger, A. Frasca
The detrimental effect of Mecp2 null astrocytes on synapses: exploring the molecular mechanisms to find novel druggable targets for Rett syndrome
2023 E. Albizzati, E.M. Florio, M. Breccia, C. Cabasino, D. Pozzi, E. Boda, C. Battaglia, C. DE PALMA, Concetta De Quattro, N. Landsberger, A. Frasca
MeCP2 deficiency in astrocytes alters synaptogenesis: new insights on Rett syndrome
2022 E. Albizzati, E.M. Florio, M. Breccia, C. Cabasino, D. Pozzi, C. DE PALMA, N. Landsberger, A. Frasca
Obesity is a risk factor for acute promyelocytic leukemia: Evidence from population and cross-sectional studies and correlation with FLT3 mutations and polyunsaturated fatty acid metabolism
2020 L. Mazzarella, E. Botteri, A. Matthews, E. Gatti, D. Di Salvatore, V. Bagnardi, M. Breccia, P. Montesinos, T. Bernal, C. Gil, T.J. Ley, M. Sanz, K. Bhaskaran, F.L. Coco, P.G. Pelicci